Breakthrough T1D · T1D · Grant
Establishing immune tolerance in islet cell replacement therapy for type 1 diabetes (T1D)
Breakthrough T1D
- Status
- Open
- Maximum funding
- Varies
- Deadline
- Rolling
- Instrument
- Grant
About this funding opportunity
Accessibility Overview Uh oh! You seem to have lost your way. Let us help you find what you were looking for: Check out our upcoming events See what's happening on the blog Sign up for a customized demo
×
About Zoom Blog Customers Our Team Careers Integrations Partners Investors Press Sustainability & ESG Zoom Cares Media Kit How to Videos Developer Platform Zoom Ventures Zoom Merchandise Store
Download Zoom Workplace App Browser Extension iPhone/iPad App Android App Zoom Virtual Backgrounds
Sales 1.888.799.9666 Contact Sales Plans & Pricing Request a Demo Webinars and Events Zoom Experience Center
Support Test Zoom Account Support Center Learning Center Zoom Community Contact Us Accessibility Developer support Privacy, Security, Legal Policies, and Modern Slavery Act Transparency Statement
Language English English Español Deutsch 简体中文 繁體中文 Français Português 日本語 Русский 한국어 Italiano Tiếng Việt Polski Türkçe Bahasa Indonesia Nederlands Svenska
Currency US Dollars $ US Dollars $
Zoom on Blog Zoom on LinkedIn Zoom on Twitter Zoom on Youtube Zoom on Facebook Zoom on Instagram
Copyright ©2026 Zoom Communications, Inc. All rights reserved. Terms Privacy Trust Center Acceptable Use Guidelines Legal & ComplianceYour Privacy ChoicesCookie Preferences
× Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...
Start a New Meeting
Livesdk Cookie Preference Center
Cookies and other similar technologies (“Cookies”) are important to the proper functioning of a site and to provide visitors with a seamless and customized experience. Zoom uses Cookies to enable you to use our site. We also use cookies to enable you to personalize your use of our site, to provide you enhanced functionality and to continuously improve the performance of our site. If you have Targeting cookies enabled below and depending on your account type or login state, we may allow third-party advertisers to show you advertising relevant to you on our website or products, using their Cookies on our site.
You can accept or decline all but Strictly Necessary Cookies, or customize your cookie settings below. You can change your cookie settings at any time. Some Strictly Necessary Cookies may transfer personal data to the United States. To learn more about how Zoom processes personal data, please visit our privacy statement.
For California Residents, you may exercise your right to “Opt-Out of the Sale of Personal Information” by toggling the button labeled “Targeting” below to off.
More information
Accept All Cookies Manage Consent Preferences Targeting Cookies
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to track your usage of our website and, depending on their policies, may combine that information with other information to show you relevant advertisements on our site and other sites. If you do not allow these cookies, you will not see personalized advertising on Zoom’s website or products.
Cookies Details Functional Cookies
Functional Cookies
These cookies enable the website to provide enhanced functionality and customization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Cookies Details Performance Cookies
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies Details Strictly Necessary Cookies
Always Active
These cookies are strictly necessary for the website to function and cannot be switched off in our systems. They are usually only set…
Topic areas: Life Sciences and Health.
Funding amount
This grant provides Varies in funding.
Deadline
Applications are accepted on a rolling basis; there is no single fixed deadline.
Who can apply
This opportunity is open to the following applicant types:
- Not specified by the program.
Eligibility
The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.
Agency
Establishing immune tolerance in islet cell replacement therapy for type 1 diabetes (T1D) is administered by Breakthrough T1D (T1D), listed via Breakthrough T1D.
Open the official opportunity page Browse all US R&D funding on GrantField
Programme data is aggregated by GrantField from public sources and may change. Always verify details on the official page before applying.